Biotheranostics logo
WebFeb 22, 2024 · - Breast Cancer Index ™ Added to National Comprehensive Cancer Network Guidelines to Predict Benefit from Extended Endocrine Therapy - Hologic, Inc. (Nasdaq: … WebJan 6, 2024 · Hologic announced late Tuesday its acquisition of Biotheranostics for $230 million, marking the second tuck-in for the medical device maker less than a week into 2024. The deal is expected to close in February. Biotheranostics is a privately-held company that sells molecular diagnostics tests for breast and metastatic cancers. Hologic said the ...
Biotheranostics logo
Did you know?
WebJan 5, 2024 · Biotheranostics, Inc. is a commercial-stage molecular diagnostics company that develops and provides diagnostic, prognostic and predictive tests that support … WebBiotheranostics privacy statement. This privacy statement governs your use of Biotheranostics’s website and all information you provide to Biotheranostics on our website. This Notice of privacy practices describes how Biotheranostics may use and disclose individuals’ health information, whether collected on our website or off-line, and …
WebBiotheranostics is a molecular diagnostics company that develops and provides diagnostic, prognostic, and predictive tests that helps physicians in the treatment of cancer patients. It offers CancerTYPE ID, a gene expression test for metastatic patients with diagnostic ambiguity, and Breast Cancer Index, a tool for breast cancer patients. WebJan 19, 2024 · Contact Data Lisa Whitmyer Biotheranostics, Inc. 216-513-7808 [email protected]
WebApr 19, 2024 · The United States alleged that Biotheranostics Inc. — a diagnostic laboratory testing company — knowingly promoted and performed the Breast Cancer Index test for breast cancer patients who … WebNov 2, 2011 · SAN DIEGO, Nov. 2, 2011 /PRNewswire/ -- bioTheranostics, Inc., a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, today announced clinical ...
WebApr 13, 2024 · Maryland Lab Permit-revised 04.13.2024 no expiration date.pdf. Pennsylvania Clinical Lab Permit-expires-08-15-2024.pdf.
WebFind company research, competitor information, contact details & financial data for Biotheranostics, Inc. of San Diego, CA. Get the latest business insights from Dun & … iphone hoesWebBeing part of Hologic only helps bring that hope closer to reality. In addition, patients facing the challenges of metastatic cancer will have broader access to our CancerTYPE ID … iphone historiaWebBiotheranostics, Inc. has been acquired by Hologic. Hologic is an innovative medical technology company whose purpose is to enable healthier lives everywhere, every day. While we discover and ... iphone hi res playerWebMar 13, 2024 · Biotheranostics doesn't have any recent trademark applications, indicating Biotheranostics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and … iphone history clearWebSep 21, 2024 · Biotheranostics, Inc., is a leading healthcare provider in the oncology field assisting physicians in the treatment of cancer patients. Its suite of commercially available proprietary molecular ... iphone hlaf of touchscreen unresponsiveWebFeb 22, 2024 · Biotheranostics also developed and markets the CancerTYPE ID test, which provides a molecular diagnosis for patients with uncertain or unknown cancers. In advanced cancer that has metastasized, it ... iphone hk dual simWebJan 6, 2024 · Hologic announced late Tuesday its acquisition of Biotheranostics for $230 million, marking the second tuck-in for the medical device maker less than a week into … iphone hold and accept